Multimodal neuroimaging study of cerebrovascular disease, amyloid deposition, and neurodegeneration in Alzheimer's disease progression
Abstract Introduction Cerebrovascular disease (CVD) is not currently considered a core pathological feature of Alzheimer's disease (AD), but mounting evidence suggests that concurrent CVD may exacerbate AD progression. The purpose of this study was first to examine the relationship among amyloi...
Main Authors: | Patrick J. Lao, Adam M. Brickman, Alzheimer's Disease Neuroimaging Initiative |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring |
Subjects: | |
Online Access: | https://doi.org/10.1016/j.dadm.2018.08.007 |
Similar Items
-
Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline
by: Isabelle Bos, et al.
Published: (2017-12-01) -
The temporal relationships between white matter hyperintensities, neurodegeneration, amyloid beta, and cognition
by: Mahsa Dadar, et al.
Published: (2020-01-01) -
Associations of Alzheimer’s disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration
by: Meng-Shan Tan, et al.
Published: (2021-01-01) -
Cerebrovascular medin is associated with Alzheimer's disease and vascular dementia
by: Raymond Q. Migrino, et al.
Published: (2020-01-01) -
TREML2 Mutation Mediate Alzheimer’s Disease Risk by Altering Neuronal Degeneration
by: Ya-Nan Song, et al.
Published: (2019-05-01)